Arrhenius
Investment Thesis & Opportunity
The Investment Thesis is based on the necessity of Negative Emissions to combat climate change, as drastic emission reduction alone is insufficient to reach net zero. Arrhenius is positioned to capitalize on the rapidly growing demand for high-integrity removal methods. The Opportunity lies in the dual-revenue stream derived from their technology: converting atmospheric CO2 into two high-value products: 1) Carbon Credits (CDR Certificates), targeting a carbon credit market volume of $22 trillion by 2050; and 2) Microalgae Biomass for the growing global Spirulina/microalgae market (projected to reach $1.2 billion+ by 2030). The company's USP is its local, cost-effective, energy-efficient, and scalable technology.
Business Model, Market Opportunity, & Strategy
The Business Model leverages its core technological innovation: the microalgae cultivation system which uses CO2 (from the atmosphere) and Nutrients (from waste-water), powered mainly by Sunlight. The strategy is phased for simultaneous market entry into the high-margin food/feed market and the nascent CDR credit market: Phase I (2026) involves buying 3 hectares of land in Portugal and implementing prototypes for both NET (Negative Emission Technology) and BEP (Bioeconomy). Phase II (2028) involves large-scale implementation and scaling up both production and CDR efforts. The strategy is anchored by secured supply contracts in the food and feed industry for their high-value microalgae biomass.
Financial Performance, Terms, & Target Returns
Arrhenius is currently seeking CHF 2 Million for its Seed Round A. This funding follows a CHF 600,000 Pre-seed round secured in 2024. The company is pursuing a series of funding rounds, with a Seed Round B of 2 Million planned for 2026 and a large Series A of CHF 10 Million planned for 2027. Revenue projections show aggressive growth, with total revenue (from Spirulina and CDR) projected to climb to over CHF 7 Million by 2035, with Annual Gross Profit reaching nearly CHF 6 Million by that time. The revenue stream from Spirulina (Food/Feed) is expected to lead growth until 2033, when CDR revenue overtakes it.
Impact Measurement, Management, & SDG Alignment
Management Team & Corporate Governance
Arrhenius AG is a Swiss-based company, featuring a technical and scientific-heavy team. It is led by three Co-Founders: Karina von dem Berge, Reto Tamburini, and Mirko Kleingries. The team includes specialized personnel like a Biotechnologist (Alissa Tophinke), a Mechanical Engineer (Ivo Steiner), and project managers. The company benefits from strong institutional support, having received funding and collaboration from the HSLU (Lucerne University of Applied Sciences and Arts), Innosuisse (Swiss Innovation Agency), and Venture Kick.
Risk Factors & Exit Strategy
No Exit Strategy is provided.
TV Episode
Podcast
